http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103168235-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6827 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2011-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103168235-B |
| titleOfInvention | For analyzing the method for the existence of disease markers in experimenter's blood sample |
| abstract | The present invention relates to a kind of method analyzing the existence of disease markers in experimenter's blood sample.Described method comprises the steps: a) from the non-nucleated blood cell of described blood sample, to extract nucleic acid with the nucleic acid fragment providing non-nucleated blood cell to extract, and b) analyze the existence of disease markers in nucleic acid fragment that described non-nucleated blood cell extracts, wherein, described disease markers is the disease specific mutagenesis in the gene of described subject cell, or wherein said disease markers is the disease specifically expressing spectrum of the gene of the cell of described experimenter. |
| priorityDate | 2010-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 370.